CTOs on the Move


 
Covers a range of chronic conditions— impacting over 50% of employees Type 2 DiabetesPrediabetesClinical ObesityNAFLD
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.daytwo.com
  • 2121, North California Boulevard
    Walnut Creek, CA USA 94596

Executives

Name Title Contact Details

Similar Companies

Golden Leaf Holdings

Built around a portfolio of recognized brands, Golden Leaf Holdings Incorporate is one of the largest cannabis oil and solution providers in North America. The Company leverages a strong management team with cannabis and food industry experience to complement its expertise in the extracting, refining and selling of cannabis oil, edibles and flower products. The Company has developed a strong consumer brand portfolio (“Golden Brands”) that includes the Golden, Proper, Chalice Farms, Liberty Reach and Jackpot Seaweed brands. In addition to leading branded products, Golden Leaf also maintains a foothold in the Oregon retail dispensary market with its award-winning chain of Chalice Farms retail stores.

Robin Medical

Robin Medical is a Pikesville, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Cato Research

Cato Research is a Durham, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

beWellnm

BeWellNM has established its online communities to serve as informative and engaging resources for the public. Our goal is to facilitate a constructive, open dialogue around the Patient Protection and Affordable Care Act, and to answer questions relate...

Oklahoma Medical Research Foundation

Established in 1946, OMRF is an independent, nonprofit biomedical research institute with more than 450 staff and over 50 labs studying cancer, heart disease, autoimmune disorders, and diseases of aging. Breakthroughs in our labs have led to three FDA-approved drugs, including the first targeted therapy approved in the U.S. for sickle cell disease and the first approved treatment for neuromyelitis optica spectrum disorder, a rare autoimmune disease. OMRF`s critical research is helping people live longer, healthier lives, one discovery at a time. Along the way, OMRF has garnered worldwide media attention, from leading scientific publications like The New England Journal of Medicine and Science to The New York Times and The Wall Street Journal. By pushing the boundaries of biomedical science, our researchers are helping to win the war against human disease, one discovery at a time.